ClinicalTrials.gg
Not yet recruitingNCT07943806Updated Nov 17, 2026

Effects of a Nurse-Led Mobilization and Breathing Exercise Protocol on Recovery After Cardiac Surgery

An interventional study of Nurse-Led Structured Mobilization and Breathing Exercise Protocol in Cardiac Surgery, Coronary Artery Bypass Grafting and Valve Replacement Surgery, sponsored by Selcuk University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Selcuk University · Not applicable, Interventional, and Health services research

How we know

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Recovery after cardiac surgery can be challenging because patients may experience pain, breathing difficulties, reduced mobility, and delays in returning to their usual activities. Early mobilization and breathing exercises are important components of postoperative nursing care.

This study aims to determine whether a nurse-led structured mobilization and breathing exercise protocol improves the quality of recovery in patients undergoing cardiac surgery compared with routine nursing care.

The study is a single-center, assessor-blinded, parallel-group randomized controlled trial. A total of 76 adult patients undergoing elective coronary artery bypass grafting or valve replacement surgery will be included. After surgery, eligible patients who have been extubated and are clinically stable will be randomly assigned to one of two groups.

Patients in the intervention group will receive a structured program of early mobilization and breathing exercises led by nurses, in addition to routine postoperative care. Patients in the control group will receive routine postoperative nursing care.

The main outcome will be the quality of recovery measured using the Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T) at 48 hours after extubation. Additional assessments will include recovery quality at other time points, pain intensity, time to first out-of-bed mobilization, delirium, length of intensive care unit and hospital stay, and postoperative pulmonary complications.

The findings may help determine whether a structured, nurse-led approach can improve recovery following cardiac surgery.

Read the detailed description

This single-center, parallel-group randomized controlled trial will evaluate the effects of a nurse-led structured mobilization and breathing exercise protocol on postoperative recovery following elective coronary artery bypass grafting or valve replacement surgery.

A total of 76 eligible adult patients will be randomly allocated in a 1:1 ratio to the intervention or control group. Randomization will be stratified by type of cardiac surgery. The intervention group will receive a structured program of progressive early mobilization and breathing exercises in addition to routine postoperative nursing care. The program will be implemented by trained nurses according to predefined clinical stability and safety criteria during the first 48 hours after extubation. The control group will receive routine postoperative nursing care.

An outcomes assessor who is unaware of group allocation will perform the designated assessments. The primary outcome is the total score on the Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T) at 48 hours after extubation. Secondary assessments will address recovery quality at additional time points, postoperative pain, mobilization, delirium, intensive care unit and hospital length of stay, and pulmonary complications.

02

Conditions studied

  • Cardiac Surgery
  • Coronary Artery Bypass Grafting
  • Valve Replacement Surgery

Keywords

  • Nurse-led intervention
  • Early mobilization
  • Breathing exercises
  • Quality of recovery
  • Postoperative nursing care
  • QoR-15
  • Randomized controlled trial
03

In context

Lead sponsor

Selcuk University is the lead sponsor of 261 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Undergoing elective coronary artery bypass grafting (CABG) or valve replacement.
  • Able to mobilize independently or with their usual assistive device before surgery.
  • Extubated following surgery.
  • Meeting predefined hemodynamic, respiratory, and neurological stability criteria.
  • Able to communicate verbally and follow simple commands.
  • No medical condition that absolutely contraindicates mobilization.
  • Providing written .

Exclusion criteria

Exclusion Criteria:

  • Emergency cardiac surgery.
  • Combined CABG and valve surgery or another major combined cardiac surgical procedure.
  • Neurological or orthopedic disease that severely limits mobilization.
  • Severe cognitive or communication impairment preventing completion of study assessments.
  • Failure to achieve the clinical stability required to initiate the study intervention after surgery.
  • Refusal to participate or withdrawal of .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Nurse-Led Mobilization and Breathing Exercise Group

    Participants in this group will receive a nurse-led structured mobilization and breathing exercise protocol in addition to routine postoperative nursing care following cardiac surgery.

    Behavioral: Nurse-Led Structured Mobilization and Breathing Exercise Protocol

  • No intervention
    Control Group

    Participants in this group will receive routine postoperative nursing care following cardiac surgery without the additional structured nurse-led mobilization and breathing exercise protocol.

Interventions

  • BehavioralNurse-Led Structured Mobilization and Breathing Exercise Protocol

    Participants allocated to the intervention group will receive a nurse-led structured mobilization and breathing exercise protocol in addition to routine postoperative nursing care following cardiac surgery. The intervention includes progressive early mobilization and breathing exercises, implemented according to the patient's clinical stability and tolerance during the postoperative recovery period.

06

What researchers measure

Primary outcomes

  1. Quality of Recovery at 48 Hours After Extubation (QoR-15T)

    Quality of recovery will be assessed using the Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T). Total scores range from 0 to 150, with higher scores indicating better postoperative recovery. The primary comparison will be between the intervention and control groups at 48 hours after extubation.

    Time frame: 48 hours after extubation

Secondary outcomes

  1. Quality of Recovery at 24 Hours After Extubation (QoR-15T)

    Quality of recovery will be assessed using the Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T). Total scores range from 0 to 150, with higher scores indicating better postoperative recovery.

    Time frame: 24 hours after extubation

  2. Quality of Recovery at 72 Hours After Extubation (QoR-15T)

    Quality of recovery will be assessed using the Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T). Total scores range from 0 to 150, with higher scores indicating better postoperative recovery.

    Time frame: 72 hours after extubation

  3. Time to First Out-of-Bed Mobilization

    Time from extubation to the first documented out-of-bed mobilization will be recorded in hours.

    Time frame: From extubation to first out-of-bed mobilization, assessed up to 48 hours after extubation

  4. Incidence of Postoperative Delirium

    Postoperative delirium will be assessed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). The outcome is the number of participants with a positive CAM-ICU assessment.

    Time frame: 24 and 48 hours after extubation

  5. Incidence of Postoperative Pulmonary Complications

    The number of participants who develop postoperative pulmonary complications will be recorded from clinical assessments and medical records.

    Time frame: From surgery through postoperative Day 7 or hospital discharge, whichever occurs first (up to 7 days)

  6. Quality of Recovery at 30 Days After Hospital Discharge (QoR-15T)

    Quality of recovery will be assessed by telephone using the Turkish version of the 15-item Quality of Recovery questionnaire (QoR-15T). Total scores range from 0 to 150, with higher scores indicating better postoperative recovery.

    Time frame: 30 days after hospital discharge

  7. Highest ICU Mobility Scale Score

    The highest level of mobilization achieved will be assessed using the ICU Mobility Scale (IMS), scored from 0 (lying in bed, passive) to 10 (walking independently). Higher scores indicate greater mobility. The highest score achieved during mobilization sessions will be recorded.

    Time frame: Within the first 48 hours after extubation

  8. Intensive Care Unit Length of Stay

    Duration of stay in the intensive care unit will be calculated from ICU admission to ICU discharge using hospital records and reported in hours.

    Time frame: Through ICU discharge, an estimated average of 3 days

  9. Hospital Length of Stay

    Duration of hospitalization will be calculated from hospital admission to hospital discharge using hospital records and reported in days.

    Time frame: Through hospital discharge, an estimated average of 7 days

  10. Postoperative Pain Intensity

    Pain intensity will be assessed at rest and during coughing or mobilization using a numerical rating scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

    Time frame: 24 hours after extubation

  11. Postoperative Pain Intensity

    Pain intensity will be assessed at rest and during coughing or mobilization using a numerical rating scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

    Time frame: 48 hours after extubation

Other outcomes

  1. Hospital Readmission Within 30 Days After Discharge

    The number of participants readmitted to the hospital within 30 days after discharge will be determined from hospital information system records.

    Time frame: Up to 30 days after hospital discharge

  2. Mortality Within 30 Days After Discharge

    The number of participants who die within 30 days after hospital discharge will be determined from available hospital information system records.

    Time frame: Up to 30 days after hospital discharge

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Apr 2028, 16 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 17, 2026
StartEst.
Dec 2026
Primary completionEst.
Apr 2028
CompletionEst.
May 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943806
Lead sponsor
Selcuk University
Responsible party
Melike Durmaz (Assistant Professor, Department of Surgical Nursing, Faculty of Nursing, Selcuk University, Selcuk University) — Principal investigator
First posted
Nov 17, 2026
Start date
Dec 2026 (estimated)
Primary completion
Apr 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Melike Durmaz, PhD
Contact
melikedurmaz@selcuk.edu.tr
+90 505 588 4006
Melike Durmaz
principal investigator · Selcuk University, Faculty of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion